Acute Myeloid Leukemia with FLT3 Mutation

Acute Myeloid Leukemia with FLT3 Mutation — Trials · CancerIndex

Clinical trials

Registered studies

15 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4
Recruiting: 3
Ph III recruiting: 0
Growth YoY: —
Industry share: 50%
Top sponsor: Shijiazhuang Yiling Pharmaceutical Co. Ltd
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (4)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04174612	AML Patients Bearing FLT3 Mutations Based on Peripheral Blast Clearance(AMELIORATE)	unknown	Phase 3	172	Gruppo Italiano Malattie EMatologiche dell'AdultoOTHER	1	Mar 2, 2022	clinicaltrials

Data updated 22 days agoSource updated Mar 2, 2022source: clinicaltrials